Summit Trail Advisors’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.25M Buy
70,397
+14,799
+27% +$263K 0.02% 392
2025
Q1
$991K Buy
55,598
+40,570
+270% +$723K 0.03% 160
2024
Q4
$448K Sell
15,028
-4,089
-21% -$122K 0.02% 235
2024
Q3
$299K Buy
+19,117
New +$299K 0.01% 549